id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-315486-pjb5v1tc	Wu, Xiaojun	Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes	2020-09-30		.txt	text/plain	1335	45	39	Are patients with hypertension and diabetes mellitus at increased risk for covid-19 infection? Effect of angiotensinconverting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2 China Medical Treatment Expert Group for C (2020a) Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis Clinical characteristics of coronavirus disease 2019 in China Risk factors associated with disease severity and length of hospital stay in covid-19 patients Temporal radiographic changes in covid-19 patients: relationship to disease severity and viral clearance Recent advances in immunity and hypertension Renin-angiotensin-aldosterone system inhibitors and risk of covid-19 Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in wuhan Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, China: a retrospective cohort study Sars-cov-2 viral load in upper respiratory specimens of infected patients Acknowledgements We acknowledge all the patients involved in this study, and appreciate all the frontline medical and nursing staff involved in the diagnosis and treatment of patients in Wuhan. What else might explain the poorer clinical outcomes of COVID-19 patients with hypertension or diabetes? To explore this question, we re-analysed the same cohort of 99 COVID-19 patients discharged from the general wards of Renmin Hospital of Wuhan University between 5 February 2020 and 14 March 2020 (Ethics approval No: WDRY2020-K124) (Liu et al. 2020a, b) .	cache/cord-315486-pjb5v1tc.txt	txt/cord-315486-pjb5v1tc.txt
